Blindness and deafness in some infants and sickle cell are among the conditions cured in recent gene therapy trials.

The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

As the inaugural Director of the new Parkinson's Research Centre, funded by the UK Dementia Research Institute and Parkinson's UK, Professor Miratul Muqit (University of Dundee, UK) hopes to untangle ...

Maryland has some of the highest cases of Lyme disease in the nation, yet funding for research is in jeopardy. Lyme disease is the most common and fastest-growing vector-borne disease in the United ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD), reports a new study at Columbia ...

New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from ...

Nutrition, disease, accidents, physical activity and labor—many of the things that humans do or experience leave traces in ...

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

Everyone’s favorite little blue pill may offer more than just a boost in the bedroom. New research suggests the erectile ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease Research Center. The center’s brain bank is preserving more than 4,000 ...

Dana Rizk, M.D., tenured professor of Medicine in the Division of Nephrology, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable research ...

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...